Volume : 10, Issue : 11, November – 2023

Title:

AN OVERVIEW CALCIUM GLUCONATE INDICATION AND PHARMACEUTICAL PROPERTIES

Authors :

Nasser Salih ALharbi , Ahmed Lafi ALharbi , Mohammed Alamri, Asma Alqasimi, Ali Al Zahrani , Mohammed Ali Adawi, ALBADER MOHAMMED YAHYA MOAFA, Turki Hussain Allugmani , Ammar Abdullah Alharbi , Adel Mohammed Juraybi

Abstract :

Calcium, a biologically occurring ion, induces the narrowing of blood vessels and exerts a beneficial effect on the force of heart contractions. The use of this method to avoid post-spinal hypotension has been proposed, but it has not been fully assessed for patients following cesarean section. Administering intravenous calcium gluconate in conjunction with morphine helps alleviate abdominal pain caused by lead poisoning resulting from the consumption of opium tainted with lead. Intravenous administration of calcium gluconate has been employed as a preventive measure against postoperative hypocalcemia (POH) subsequent to parathyroidectomy for secondary hyperparathyroidism in individuals with chronic kidney disease (CKD).

Cite This Article:

Please cite this article in Nasser Salih ALharbi et al, An Overview Calcium Gluconate Indication And Pharmaceutical Properties, Indo Am. J. P. Sci, 2023; 10 (11).

Number of Downloads : 10

References:

1. Al Omari MM, Rashid IS, Qinna NA, Jaber AM, Badwan AA. Calcium Carbonate. Profiles Drug Subst Excip Relat Methodol. 2016;41:31-132.
2. Salisbury BH, Terrell JM. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): Aug 8, 2023. Antacids.
3. Karatzas A, Paridis D, Kozyrakis D, Tzortzis V, Samarinas M, Dailiana Z, Karachalios T. Fanconi syndrome in the adulthood. The role of early diagnosis and treatment. J Musculoskelet Neuronal Interact. 2017 Dec 01;17(4):303-306.
4. Bilezikian JP, Brandi ML, Cusano NE, Mannstadt M, Rejnmark L, Rizzoli R, Rubin MR, Winer KK, Liberman UA, Potts JT. Management of Hypoparathyroidism: Present and Future. J Clin Endocrinol Metab. 2016 Jun;101(6):2313-24.
5. Jorde R, Szumlas K, Haug E, Sundsfjord J. The effects of calcium supplementation to patients with primary hyperparathyroidism and a low calcium intake. Eur J Nutr. 2002 Dec;41(6):258-63.
6. Nakamura Y, Suzuki T, Yoshida T, Yamazaki H, Kato H. Vitamin D and Calcium Are Required during Denosumab Treatment in Osteoporosis with Rheumatoid Arthritis. Nutrients. 2017 Apr 26;9(5).
7. Maton PN, Burton ME. Antacids revisited: a review of their clinical pharmacology and recommended therapeutic use. Drugs. 1999 Jun;57(6):855-70.
8. Ching CK, Lam SK. Antacids. Indications and limitations. Drugs. 1994 Feb;47(2):305-17.
9. Matzkies F, Köhler M, Webs B. [The effect of 4 different antacids on the gastrointestinal tract and mineral metabolism]. Fortschr Med. 1984 Jun 28;102(24):661-5.
10. Institute of Medicine (US) Standing Committee on the Scientific Evaluation of Dietary Reference Intakes. Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride. National Academies Press (US); Washington (DC): 1997.
11. Antonini R, Biandrate F, Piccolini M, Francia L. [Oncocytoma of the kidney: a diagnostic and therapeutic dilemma]. Minerva Chir. 1989 Oct 15;44(19):2113-8.
12. Tarnawski A, Ahluwalia A, Jones MK. Gastric cytoprotection beyond prostaglandins: cellular and molecular mechanisms of gastroprotective and ulcer healing actions of antacids. Curr Pharm Des. 2013;19(1):126-32.
13. Weberg R, Berstad K, Berstad A. Acute effects of antacids on gastric juice components in duodenal ulcer patients. Eur J Clin Invest. 1990 Oct;20(5):511-5.
14. Hade JE, Spiro HM. Calcium and acid rebound: a reappraisal. J Clin Gastroenterol. 1992 Jul;15(1):37-44.
15. Preclik G, Stange EF, Gerber K, Fetzer G, Horn H, Schneider A, Ditschuneit H. Effect of antacid treatment on endogenous prostaglandin synthesis in human antral and duodenal mucosa. Dig Dis Sci. 1989 Dec;34(12):1860-4.
16. Rodriguez-Stanley S, Ahmed T, Zubaidi S, Riley S, Akbarali HI, Mellow MH, Miner PB. Calcium carbonate antacids alter esophageal motility in heartburn sufferers. Dig Dis Sci. 2004 Nov-Dec;49(11-12):1862-7.
17. Moog R. Adverse effects in peripheral progenitor cell collection: a 7 year experience. J Hematother Stem Cell Res. 2001;10:675-680.
18. Hester JP, McCullough J, Mishler JM, Szymanski IO. Dosage regimens for citrate anticoagulants. J Clin Apher. 1983;1:149-157.
19. Bolan CD, Cecco SA, Wesley RA, et al. Controlled study of citrate effects and response to IV calcium administration during allogenic peripheral blood progenitor cell donation. Transfusion. 2002;42:935-946.
20. Buchta C, Macher M, Bieglmayer C, Höcker P, Dettke M. Reduction of adverse citrate reactions during autologous large-volume PBPC apheresis by continuous infusion of calcium–gluconate. Transfusion. 2003; 43:1615-1621.
21. Azoubel MC, Menezes AM, Bezerra D, Oriá RB, Ribeiro RA, Brito GA. Comparison of etoricoxib and indomethacin for the treatment of experimental periodontitis in rats. Braz J Med Biol Res 2007; 40: 117–25.
22. Tani-Ishii N, Minamida G, Saitoh D, Chieda K, Omuro H, Sugaya A et al. Inhibitory effects of incadronate on the progression of rat experimental periodontitis by porphyromonas gingivalis infection. J Periodontol 2003; 74: 603–9.
23. Samira S, Ferrand C, Peled A, Nagler A, Tovbin Y, Ben-Hur H et al. Tumor necrosis factor promotes human T-cell development in nonobese diabetic/severe combined immunodeficient mice. Stem Cells 2004; 22: 1085–100.
24. Botelho MA, Rao VS, Carvalho CB, Bezerra-Filho JG, Fonseca SG, Vale ML et al. Lippia sidoides and Myracrodruon urundeuva gel prevents alveolar bone resorption in experimental periodontitis in rats. J Ethnopharmacol 2007; 113: 471–8.
25. Sunyecz JA. The use of calcium and vitamin D in the management of osteoporosis. Ther Clin Risk Manag. 2008 Aug;4(4):827-36.
26. Recker RR. Calcium absorption and achlorhydria. N Engl J Med. 1985 Jul 11;313(2):70-3.
27. Wang H, Bua P, Capodice J. A comparative study of calcium absorption following a single serving administration of calcium carbonate powder versus calcium citrate tablets in healthy premenopausal women. Food Nutr Res. 2014;58
28. Nicar MJ, Pak CY. Calcium bioavailability from calcium carbonate and calcium citrate. J Clin Endocrinol Metab. 1985 Aug;61(2):391-3.
29. Weinstein R, Haynes S, Zhao Y, et al. A liquid calcium+vitamin D3 supple- ment is effective prophylaxis against hypocalcemic toxicity during apheresis platelet donation. J Clin Apher. 2018;33:60-64.
30. Hegde V, Setia R, Soni S, et al. Prophylactic low dose continuous calcium infusion during peripheral blood stem cell (PBSC) collections to reduce citrate related toxicity. Transfus Apher Sci. 2016;54:373-376.
31. Aub JC, Fairhall LT, Minot AS, Reznikoff P. Lead Poisoning. Medicine. 1925;4:1.
32. Jin Y, Yu F, Liao Y, Liu S, Liu M, Xu J, Yang J. Therapeutic efficiency of succimer used with calcium and ascorbic acid in the treatment of mild lead-poisoning. Environ Toxicol Pharmacol. 2011;31(1):137–142.